Talphera (TLPH) Preferred Dividend Payments (2022)
Talphera's (TLPH) quarterly Preferred Dividend Payments came in at -$740000.0 in Q4 2022, down 15.81% quarter-over-quarter from -$639000.0 in Q3 2022.
Talphera (TLPH) Preferred Dividend Payments (2022) Analysis & Trends
Talphera's Preferred Dividend Payments history runs 1 years deep, the most recent figure standing at -$740000.0 for Q4 2022.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to -$740000.0 in Q4 2022; TTM through Dec 2023 was -$740000.0, a 112.07% decrease from a year earlier, with the FY2022 full-year figure at $5.2 million, changed N/A from the prior year.
- Preferred Dividend Payments declined to -$740000.0 in Q4 2022 per TLPH's latest filing, from -$639000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $7.5 million in Q2 2022 and bottomed at -$740000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -740,000.00 |
| Sep 30, 2022 | -639,000.00 |
| Jun 30, 2022 | 7.51 Mn |